ORAL CARE PRODUCTS
ABOUT AUTHOR:
Vinay Kumar Singh
Chief Research Officer,
Paramount Cosmetics India,
Bangalore, Karnataka
The rising cost of raw materials, stringent regulatory requirements and increasingly competitive environment all are rapidly eroding the profit margins of many antibiotic manufacturers. BCC Research reveals in its new report that these challenges, and the growing problem of antibiotic resistance, have dramatically shifted the business models of some of the industry’s leading pharmaceutical companies.
Spending on programmes to control India’s three main communicable diseases malaria, tuberculosis and leprosy increased seven percent over five years while cases reported, taken together, increased 32 percent, according to an IndiaSpend analysis of government data.
[adsense:336x280:8701650588]
The money allocated for key centrally sponsored social schemes — Integrated Child Development Services (ICDS), Sarva Shiksha Abhiyan (SSA or universal education programme) and National Health Mission — has declined 10 percent, 7.5 percent and 3.6 percent over two years.